US-based virtual women’s health clinic Visana Health has announced the successful close of a $24 million Series A funding round, as the company looks to grow its reach and broaden its clinical services. The round was led by Noro-Moseley Partners, with support from The Cigna Group Ventures and Intermountain Ventures, alongside continued backing from existing investors Flare Capital Partners and Frist Cressey Ventures.
Visana, which provides comprehensive virtual healthcare to women aged 18 to 65, has seen rapid growth since its seed round. The company now partners with national and regional health plans that together cover more than 35 million individuals. Additionally, over 40 employers, representing over 1 million lives, have adopted Visana’s services for their workforce. Based on its current growth, the company expects to serve nearly 50,000 women by 2025.
“The reality is that many women in theworkforce are silently managing multiple chronic conditions – the average Visana patient has 3 to 4. By not addressing this, employers carry unnecessary costs,” said Joe Connolly, Co-founder and CEO of Visana Health. “This financing is a recognition of the extraordinary progress we’ve made since our seed round– scaling nationwide to all 50 states, expanding our clinical scope, and proving that women’s healthcare can deliver both outstanding outcomes and actuarily-verified cost savings at scale.”
Women’s health is reportedly one of the top five areas of healthcare spend for employers, on par with conditions like cancer and musculoskeletal issues. However, a significant portion, around 20%, of these costs are related to issues that don’t always appear in insurance claims. According to actuarial data, Visana helps reduce employer medical costs by 34%, cuts back on unnecessary procedures by 78%, and generates more than $2,400 in yearly savings per enrollee. The figures are credited to Visana’s clinically-backed approach, which aims to address complex health concerns across the full continuum of care.
“Visana has consistently demonstrated a commitment to women’s health, helping many of our employees feel heard for the first time. Their secret sauce is the individualized care and tailored solutions they help provide for every patient,” said Michele Arnette, Lead Benefits Analyst, Lumen. “Their solutions provide employees with top-notch benefits that exceed our high standards. Their dedication to customer satisfaction and ability to deliver value-added services make them an ideal partner for our organization.”
“Visana has achieved the pinnacle of healthcare – a care model that delivers measurable improvements in patient outcomes while reducing costs,” said Spence McClelland, General Partner, Healthcare, Noro-Moseley Partners. “As we look for emerging, disruptive healthcare companies to support, Visana clearly fits that mold. We’re thrilled to back a team that is setting a new standard for comprehensive women’s health.”
The fresh funding will support Visana’s plans to branch into additional areas such as weight management, cardiometabolic care, and chronic conditions like diabetes, thyroid disease, and cardiovascular issues. The firm also plans to strengthen its AI infrastructure, aiming to improve provider efficiency and reduce administrative strain, an early sign, it says, of its ambition to reshape how care is delivered for both clinicians and patients.
